Frontiers in adjuvant therapy in stage II-IIi melanoma
Eggermont, A.M.
Tumori 87(4): S60-S63
2001
ISSN/ISBN: 0300-8916 PMID: 11693827 Document Number: 527115
Document emailed within 1 workday
Related Documents
Tricarico, M.; Nunziata, C.; Atzori, F.; Concolino, F.; Macchini, V.; D'Atri, S.; Prete, S.P.; Turriziani, M.; Lanzilli, G.; Sera, F.; Abeni, D.; Albanesi, V.; Bonmassar, E.; Pagani, E. 2004: Adjuvant therapy of melanoma patients (stage II, III): a pilot immuno-toxicological study Journal of Experimental and Clinical Cancer Research: Cr 23(4): 573-578Postow, M.A. 2018: Does adjuvant therapy for high-risk melanoma with either immunotherapy or targeted therapy affect therapeutic choices at relapse? Clinical Advances in Hematology and Oncology: H&o 16(5): 353-355
Schreml, W. 1982: Malignant melanoma - adjuvant systemic therapy Aktuelle Probleme in Chirurgie und Orthopadie 22: 64-65
Agarwala, S.S.; Kirkwood, J.M. 2002: Update on adjuvant interferon therapy for high-risk melanoma Oncology 16(9): 1177-87; Discussion 1190-2 1197
Johnson, D.M.; Hayat, S.Q.; Burton, G.V. 1999: Rheumatoid arthritis complicating adjuvant interferon-alpha therapy for malignant melanoma Journal of Rheumatology 26(4): 1009-1010
McMasters, K.M.; Sober, A.; Kirkwood, J.M. 2003: Sentinel lymph node biopsy and adjuvant therapy for melanoma: evidence revisited Archives of Dermatology 139(1): 99; Author Reply 99-100
Kadakia, K.C.; Worrilow, W.M.; Coley, H.; Salem, M.E. 2019: Optimal duration of adjuvant therapy for stage IIi colon cancer Clinical Advances in Hematology and Oncology: H&o 17(5): 289-298
Horová, H.; Růzicková, J.; Jezková, B.; Horová, I.; Budíková, M.; Dörr, A. 2004: Adjuvant radiotherapy in the therapy of uterine cancer in the first clinical stage Ceska Gynekologie 69(5): 366-371
Richter, G.; Heidenbluth, I.; Heidelbach, U. 1982: Endolymphatic radionuclide adjuvant therapy of melanoma and its side effects on the cellular immune system Dermatologische Monatschrift 168(12): 797-806
McGuire, W.P. 1998: Current aspects of adjuvant therapy of early stage ovarian cancer Zentralblatt für Gynakologie 120(3): 93-97
Wolff, A.C. 2005: Current status of taxanes as adjuvant therapy for early-stage breast cancer International Journal of Fertility and Women's Medicine 50(5 Pt 1): 227-229
Marshall, J.S.; Gordon, N.H.; Hubay, C.A.; Pearson, O.H. 1987: Assessment of tamoxifen as adjuvant therapy in stage Ii breast cancer: a long-term follow-up Journal of Laboratory and Clinical Medicine 109(3): 300-307
Movsas, B. 2001: Role of adjuvant therapy in resected stage II/IIIA non-small-cell lung cancer Oncology 15(12): 1549-1558
Dede, M.; Yenen, M.C.; Goktolga, U.; Duru, N.K.; Guden, M.; Dilek, S.; Pabuccu, R. 2004: Is adjuvant therapy necessary for peritoneal cytology-positive surgical-pathologic Stage I endometrial cancer? Preliminary results European Journal of Gynaecological Oncology 25(5): 591-593
Lin, H.; ChangChien, C.C.; Chang, S.Y.; Leung, S.W. 1998: Survival advantages and complications of adjuvant therapy in early-stage cervical cancer with pelvic node metastasis Changgeng Yi Xue Za Zhi 21(4): 383-390
Wagner, R.I.; Kozlov, A.P.; Moskalik, K.G. 1996: Results of pulsed laser therapy of stage-i melanoma of the skin subjected to incisional biopsy Voprosy Onkologii 42(1): 101-102
Syrigos, K.N.; Konstantinou, M.; Sepsas, E.; Papamichales, G.; Loullias, A.; Belenis, I.; Skottis, I.; Charpidou, A.; Roussos, C. 2007: Biweekly administration of docetaxel and gemcitabine as adjuvant therapy for stage II and IIIA non-small cell lung cancer: a phase II study Anticancer Research 27(4c): 2887-2892
Sato, Y.; Yajima, K.; Kosugi, S-ichi.; Muneoka, Y.; Ichikawa, H.; Hanyu, T.; Sakamoto, K.; Ishikawa, T.; Wakai, T. 2014: Current status of adjuvant chemotherapy in patients with p-Stage II and p-Stage III gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(8): 961-964
Beiteke, U.; Ruppert, P.; Garbe, C.; Oxenfarth, R.; Kastl, I.; Türker, T.; Tronnier, H.; Frosch, P.J. 1993: Adjuvant therapy of primary malignant melanoma with natural human interferon-beta. Significant survival advantage in 96 treated patients in comparison with 288 untreated symptomatic controls Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 44(6): 365-371
Pichatechaiyoot, A.; Buhachat, R.; Boonyapipat, S.; Kanjanapradit, K. 2014: Radiation, chemotherapy or combined modality therapy in adjuvant treatment for stage IIi endometrial carcinoma in lower southern Thailand: disease recurrence and overall survival Journal of the Medical Association of Thailand 97(3): 274-282